Potential Role of New Anticoagulants for Prevention and Treatment of Venous Thromboembolism in Cancer Patients

Vascular Health and Risk Management
doi 10.2147/vhrm.s35843
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Therapeutic Advances in Hematology
Hematology
2011English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2012English

Prevention and Treatment of Venous Thromboembolism With New Oral Anticoagulants: A Practical Update for Clinicians

Thrombosis
Cardiovascular MedicineHematologyCardiology
2013English

Prevention of Venous Thromboembolism in Cancer Patients

Egyptian Journal of Hematology and Bone Marrow Transplantation
2015English

Recent Advances in the Treatment and Prevention of Venous Thromboembolism in Cancer Patients: Role of the Direct Oral Anticoagulants and Their Unique Challenges

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

The Treatment of Venous Thromboembolism With New Oral Anticoagulants

Italian Journal of Medicine
Medicine
2013English

Role of New Anticoagulants for the Prevention of Venous Thromboembolism After Major Orthopaedic Surgery and in Hospitalised Acutely Ill Medical Patients

Thrombosis and Haemostasis
Hematology
2012English

Hypoalbuminemia for the Prediction of Venous Thromboembolism and Treatment of Direct Oral Anticoagulants in Metastatic Gastric Cancer Patients

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities

Drugs
Pharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy